You are here: Home » Current Affairs » Coronavirus » News
Business Standard

6 months post second dose ideal for booster: Bharat Biotech's Krishna Ella

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Krishna Ella said

Topics
Bharat Biotech | Coronavirus Vaccine | Vaccination

Press Trust of India  |  New Delhi 

Krishna Ella, chairman & MD,  Bharat Biotech
Krishna Ella, chairman & MD, Bharat Biotech

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Chairman and Managing Director Krishna Ella said on Wednesday, and also emphasised the importance of having a nasal vaccine.

He also pointed out that his company was the first in the world to develop a Zika vaccine.

Taking the Covaxin vaccine by the Prime Minister Narendra Modi showed confidence in Indian Science, he said at the Times Now Summit 2021.

"The ideal time for a booster dose is six months after the second dose," Ella stated.

is also looking at nasal vaccine as a booster dose as its scaling up capacity is very easy when compared with Covaxin, he added.

About the importance of nasal vaccine, he said the entire world is looking at nasal vaccines. That is the only way to stop transmission. Everyone is trying to figure out the immunology and fortunately, has figured it out.

"We are coming out with a nasal vaccine, we are thinking that Covaxin can be given as first dose, the second dose can be given a nasal, that is also strategically, scientifically very important because with the second dose, if it is a nasal one, you stop the transmission of the virus...," Ella said.

Nasal vaccine works well if someone has been infected or if someone has been vaccinated with one dose, he added.

About the PM taking the Covaxin shot, he said, "What would a scientist like to have? A country head taking his vaccine. That is the best satisfaction a scientist can get... It shows confidence in the Indian science, confidence in the startup, and confidence in our innovation...".

Speaking about a vaccine for Zika, Ella said Bharat Biotech is ready with a vaccine for Zika virus. Phase I is complete. The government has to take up more trials because there are more cases now.

"We were the first company in the world to develop the Zika vaccine in 2014... We were the first one to file for a global patent for Zika vaccine", he added.
 

Vietnam gives nod to Covaxin

Vietnam has approved Covaxin vaccine for emergency use, the ninth to be endorsed in the country, the country’s health ministry said on Wednesday. The government said in July it was seeking to secure 15 million doses of the Covaxin vaccine made by Bharat Biotech.
 
Reuters

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 10 2021. 15:33 IST
RECOMMENDED FOR YOU